The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Markel, G.
Right arrow Articles by Mandelboim, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Markel, G.
Right arrow Articles by Mandelboim, O.
The Journal of Immunology, 2002, 168: 2803-2810.
Copyright © 2002 by The American Association of Immunologists

CD66a Interactions Between Human Melanoma and NK Cells: A Novel Class I MHC-Independent Inhibitory Mechanism of Cytotoxicity1

Gal Markel*, Niva Lieberman*, Gil Katz*, Tal I. Arnon*, Michal Lotem{dagger}, Olga Drize{dagger}, Richard S. Blumberg{ddagger}, Erez Bar-Haim§, Reuven Mader, Lea Eisenbach§ and Ofer Mandelboim2,*

* Lautenberg Center for General and Tumor Immunology and {dagger} Sharet Institute of Oncology, Hadassah Medical School, Jerusalem, Israel; {ddagger} Gastroenterology Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115; § Department of Immunology, Weizmann Institute of Science, Rehovot, Israel; and Department of Internal Medicine, HaEmek Medical Center, Afula, Israel

NK cells are able to kill virus-infected and tumor cells via a panel of lysis receptors. Cells expressing class I MHC proteins are protected from lysis primarily due to the interactions of several families of NK receptors with both classical and nonclassical class I MHC proteins. In this study we show that a class I MHC-deficient melanoma cell line (1106mel) is stained with several Ig-fused lysis receptors, suggesting the expression of the appropriate lysis ligands. Surprisingly, however, this melanoma line was not killed by CD16-negative NK clones. The lack of killing is shown to be the result of homotypic CD66a interactions between the melanoma line and the NK cells. Furthermore, 721.221 cells expressing the CD66a protein were protected from lysis by YTS cells and by NK cells expressing the CD66a protein. Redirected lysis experiments demonstrated that the strength of the inhibitory effect is correlated with the levels of CD66a expression. Finally, the expression of CD66a protein was observed on NK cells derived from patients with malignant melanoma. These findings suggest the existence of a novel class I MHC-independent inhibitory mechanism of human NK cell cytotoxicity. This may be a mechanism that is used by some of the class I MHC-negative melanoma cells to evade attack by CD66a-positive NK cells.




This article has been cited by other articles:


Home page
J. Virol.Home page
H. Achdout, I. Manaster, and O. Mandelboim
Influenza Virus Infection Augments NK Cell Inhibition through Reorganization of Major Histocompatibility Complex Class I Proteins
J. Virol., August 15, 2008; 82(16): 8030 - 8037.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. S. W. Lee, M. A. Ostrowski, and S. D. Gray-Owen
CEACAM1 Dynamics during Neisseria gonorrhoeae Suppression of CD4+ T Lymphocyte Activation
J. Immunol., May 15, 2008; 180(10): 6827 - 6835.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Mizrahi, E. Yefenof, M. Gross, P. Attal, A. Ben Yaakov, D. Goldman-Wohl, B. Maly, N. Stern, G. Katz, R. Gazit, et al.
A phenotypic and functional characterization of NK cells in adenoids
J. Leukoc. Biol., November 1, 2007; 82(5): 1095 - 1105.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Stern-Ginossar, S. Nedvetzki, G. Markel, R. Gazit, G. Betser-Cohen, H. Achdout, M. Aker, R. S. Blumberg, D. M. Davis, B. Appelmelk, et al.
Intercellular Transfer of Carcinoembryonic Antigen from Tumor Cells to NK Cells
J. Immunol., October 1, 2007; 179(7): 4424 - 4434.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Schmitter, S. Pils, V. Sakk, R. Frank, K.-D. Fischer, and C. R. Hauck
The Granulocyte Receptor Carcinoembryonic Antigen-Related Cell Adhesion Molecule 3 (CEACAM3) Directly Associates with Vav to Promote Phagocytosis of Human Pathogens
J. Immunol., March 15, 2007; 178(6): 3797 - 3805.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. Yu, E. M. C. Chow, H. Wong, J. Gu, O. Mandelboim, S. D. Gray-Owen, and M. A. Ostrowski
CEACAM1 (CD66a) Promotes Human Monocyte Survival via a Phosphatidylinositol 3-Kinase- and AKT-dependent Pathway
J. Biol. Chem., December 22, 2006; 281(51): 39179 - 39193.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
B. Albarran-Somoza, R. Franco-Topete, V. Delgado-Rizo, F. Cerda-Camacho, L. Acosta-Jimenez, M. Lopez-Botet, and A. Daneri-Navarro
CEACAM1 in Cervical Cancer and Precursor Lesions: Association With Human Papillomavirus Infection
J. Histochem. Cytochem., December 1, 2006; 54(12): 1393 - 1399.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Markel, R. Seidman, N. Stern, T. Cohen-Sinai, O. Izhaki, G. Katz, M. Besser, A. J. Treves, R. S. Blumberg, R. Loewenthal, et al.
Inhibition of Human Tumor-Infiltrating Lymphocyte Effector Functions by the Homophilic Carcinoembryonic Cell Adhesion Molecule 1 Interactions
J. Immunol., November 1, 2006; 177(9): 6062 - 6071.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
S. Iizuka, T. Kaifu, A. Nakamura, M. Obinata, and T. Takai
Establishment and Functional Characterization of Novel Natural Killer Cell Lines Derived from a Temperature-Sensitive SV40 Large T Antigen Transgenic Mouse
J. Biochem., August 1, 2006; 140(2): 255 - 265.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Betser-Cohen, G. Katz, T. Gonen-Gross, N. Stern, T. I. Arnon, H. Achdout, R. Gazit, and O. Mandelboim
Reduced KIR2DL1 Recognition of MHC Class I Molecules Presenting Phosphorylated Peptides.
J. Immunol., June 1, 2006; 176(11): 6762 - 6769.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. Colonna
Cytolytic responses: cadherins put out the fire
J. Exp. Med., February 20, 2006; 203(2): 261 - 264.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
N. Azuz-Lieberman, G. Markel, S. Mizrahi, R. Gazit, J. Hanna, H. Achdout, R. Gruda, G. Katz, T. I. Arnon, S. Battat, et al.
The involvement of NK cells in ankylosing spondylitis
Int. Immunol., July 1, 2005; 17(7): 837 - 845.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
E Puxeddu, J A Knauf, M A Sartor, N Mitsutake, E P Smith, M Medvedovic, C R Tomlinson, S Moretti, and J A Fagin
RET/PTC-induced gene expression in thyroid PCCL3 cells reveals early activation of genes involved in regulation of the immune response
Endocr. Relat. Cancer, June 1, 2005; 12(2): 319 - 334.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Stern, G. Markel, T. I. Arnon, R. Gruda, H. Wong, S. D. Gray-Owen, and O. Mandelboim
Carcinoembryonic Antigen (CEA) Inhibits NK Killing via Interaction with CEA-Related Cell Adhesion Molecule 1
J. Immunol., June 1, 2005; 174(11): 6692 - 6701.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Markel, R. Gruda, H. Achdout, G. Katz, M. Nechama, R. S. Blumberg, R. Kammerer, W. Zimmermann, and O. Mandelboim
The Critical Role of Residues 43R and 44Q of Carcinoembryonic Antigen Cell Adhesion Molecules-1 in the Protection from Killing by Human NK Cells
J. Immunol., September 15, 2004; 173(6): 3732 - 3739.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Katz, R. Gazit, T. I. Arnon, T. Gonen-Gross, G. Tarcic, G. Markel, R. Gruda, H. Achdout, O. Drize, S. Merims, et al.
MHC Class I-Independent Recognition of NK-Activating Receptor KIR2DS4
J. Immunol., August 1, 2004; 173(3): 1819 - 1825.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C.-J. Chen and J. E. Shively
The Cell-Cell Adhesion Molecule Carcinoembryonic Antigen-Related Cellular Adhesion Molecule 1 Inhibits IL-2 Production and Proliferation in Human T Cells by Association with Src Homology Protein-1 and Down-Regulates IL-2 Receptor
J. Immunol., March 15, 2004; 172(6): 3544 - 3552.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
U. Sundberg, N. Beauchemin, and B. Obrink
The cytoplasmic domain of CEACAM1-L controls its lateral localization and the organization of desmosomes in polarized epithelial cells
J. Cell Sci., March 1, 2004; 117(7): 1091 - 1104.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Markel, H. Mussaffi, K.-L. Ling, M. Salio, S. Gadola, G. Steuer, H. Blau, H. Achdout, M. de Miguel, T. Gonen-Gross, et al.
The mechanisms controlling NK cell autoreactivity in TAP2-deficient patients
Blood, March 1, 2004; 103(5): 1770 - 1778.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. I. Arnon, H. Achdout, N. Lieberman, R. Gazit, T. Gonen-Gross, G. Katz, A. Bar-Ilan, N. Bloushtain, M. Lev, A. Joseph, et al.
The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46
Blood, January 15, 2004; 103(2): 664 - 672.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Achdout, T. I. Arnon, G. Markel, T. Gonen-Gross, G. Katz, N. Lieberman, R. Gazit, A. Joseph, E. Kedar, and O. Mandelboim
Enhanced Recognition of Human NK Receptors After Influenza Virus Infection
J. Immunol., July 15, 2003; 171(2): 915 - 923.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
G. Greicius, E. Severinson, N. Beauchemin, B. Obrink, and B. B. Singer
CEACAM1 is a potent regulator of B cell receptor complex-induced activation
J. Leukoc. Biol., July 1, 2003; 74(1): 126 - 134.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
D. Finkenzeller, B. Fischer, S. Lutz, H. Schrewe, T. Shimizu, and W. Zimmermann
Carcinoembryonic Antigen-Related Cell Adhesion Molecule 10 Expressed Specifically Early in Pregnancy in the Decidua Is Dispensable for Normal Murine Development
Mol. Cell. Biol., January 1, 2003; 23(1): 272 - 279.
[Abstract] [Full Text]


Home page
JCOHome page
T. A. Plunkett and P. A. Ellis
CEACAM1: A Marker With a Difference or More of the Same?
J. Clin. Oncol., November 1, 2002; 20(21): 4273 - 4275.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.